发明名称 5-MEMBERED HETEROCYCLIC DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
摘要 <p>Disclosed is a compound useful as a prophylactic or therapeutic agent for a disease induced by abnormal plasma uric acid level or the like. Specifically disclosed is a 5-membered heterocyclic derivative represented by the general formula (I), a prodrug or salt thereof, or the like, which has a xanthine oxidase inhibitory activity and is useful as a prophylactic or therapeutic agent for a disease induced by abnormal plasma uric acid level. In the formula (I), T represents a nitro, a cyano or the like; the ring J represents an aryl or a heteroaryl; Q represents a carboxy, a 5-tetrazolyl or the like; Y represents H, OH, NH2, a halogen,a haloalkyl or the like; X1 and X2 independently represent CR2 or N; and R2 represents H, an alkyl or the like; and R1 represents a halogen, a cyano, a haloalkyl, A-D-E-G-L-M, -N(D-L-M)2 or the like [wherein A represents a single bond, O, S or the like; D, G and M independently represent an alkylene which may be substituted, a cycloalkylene, a heterocycloalkylene, an arylene, a heteroarylene or the like; and E and L independently represent a single bond, O, S, COO, SO2 or the like].</p>
申请公布号 CA2682393(C) 申请公布日期 2015.03.17
申请号 CA20082682393 申请日期 2008.04.10
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 SHIMIZU, KAZUO;TAKIGAWA, YASUSHI;FUJIKURA, HIDEKI;IIZUKA, MASATO;HIRATOCHI, MASAHIRO;KIKUCHI, NORIHIKO
分类号 C07D207/34;A61K31/402;A61K31/404;A61K31/415;A61K31/4155;A61K31/427;A61K31/4439;A61K31/454;A61K31/5377;A61K45/00;A61P13/02;A61P19/06;A61P43/00;C07D231/14;C07D231/16;C07D231/20;C07D231/38;C07D231/40;C07D401/04;C07D403/04;C07D405/04;C07D405/06;C07D409/04;C07D409/12;C07D417/04 主分类号 C07D207/34
代理机构 代理人
主权项
地址